OCUL insider files to sell 3,510 shares

Nadia K. Waheed submitted a Form 144 reporting a proposed sale of 3,510 shares of common stock tied to restricted stock vesting under a registered plan, dated 02/11/2026.

Rhea-AI Filing Summary

Nadia K. Waheed submitted a Form 144 reporting a proposed sale of 3,510 shares of common stock tied to restricted stock vesting under a registered plan, dated 02/11/2026. The filing also shows 7,863 shares were sold on 02/12/2026.

Insights

Securities Compliance Counsel

Routine Form 144 notice of an affiliate sale tied to vested restricted stock.

The filing lists a proposed sale of 3,510 shares dated 02/11/2026 described as "restricted stock vesting under a registered plan" and an executed sale of 7,863 shares on 02/12/2026.

Because Form 144s are notice filings, cash‑flow treatment and sale method are not specified in the excerpt; subsequent transaction details or broker confirmations would appear in other filings or trading records.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OCUL Form 144 filed by Nadia K. Waheed report?

The filing reports a proposed sale of 3,510 shares tied to restricted stock vesting on 02/11/2026, and a sale of 7,863 shares on 02/12/2026, per the excerpt.

Does the Form 144 specify how the OCUL shares will be sold?

No, the excerpt describes the shares as "restricted stock vesting under a registered plan" but does not specify the sale method or broker execution details in the provided text.

Who is the reporting person on the OCUL Form 144?

The reporting person named in the excerpt is Nadia K. Waheed, with an address listed in Bedford, MA, as the individual associated with the reported transactions.

Are the amounts in the Form 144 confirmed as completed sales?

The excerpt shows a sale of 7,863 shares on 02/12/2026 and a proposed sale of 3,510 shares dated 02/11/2026; confirmation beyond those entries is not included here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002023884
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	NADIA K. WAHEED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3510	27170.21	217691779	02/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Restricted stock vesting under a registered plan	Issuer			3510	02/11/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NADIA K. WAHEED 15 Crosby Drive Bedford MA 01730	Common	02/12/2026	7863	71082.31

144: Remarks and Signature

Remarks	This is a Sell to Cover transaction
Date of Notice	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nadia Waheed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)